Rotigotine Patch is Effective for Levodopa (L-Dopa)-Induced Dyspnea: A Case Report

Area of Science:

• Neurology
• Pharmacology

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder with rising prevalence.
• Motor symptoms like impaired mobility and balance are well-known, but respiratory complications, particularly dyspnea linked to levodopa (L-dopa) treatment, are less recognized.

Observation:

• An 88-year-old female PD patient developed fever, dyspnea, and dysphagia post-L-dopa initiation.
• Neurological exam showed significant motor impairments; chest imaging revealed right diaphragmatic elevation and atelectasis.
• Attempts to adjust L-dopa administration (intravenous to nasogastric) led to severe dyskinesias and respiratory distress.

Findings:

• Transitioning the patient to a transdermal rotigotine patch resulted in complete resolution of dyspnea and dyskinesias.
• The rotigotine treatment also led to improvements in motor function and daily living activities.
• This suggests rotigotine may offer a viable alternative for managing L-dopa-induced respiratory complications.

Implications:

• Rotigotine may provide stable blood concentrations, mitigating levodopa-induced dyspnea and dyskinesias.
• This case highlights rotigotine's potential therapeutic role in managing specific PD treatment side effects.
• Further research is needed to understand the mechanisms of L-dopa-induced respiratory depression and confirm rotigotine's efficacy.